[pubmed] Prospective studies on the efficacy of rituximab for myasthenia gravis are warranted
Posté : 04 août 2020 12:00
Eur J Neurol. 2020 Aug 4. doi: 10.1111/ene.14461. Online ahead of print.
ABSTRACT
With interest we read the article by Dos Santos et al. about a retrospective, multicenter study on the effect and safety of rituximab (RTX) in patients >18y with myasthenia gravis (MG) in 6 centers of Western France [1]. It was concluded that RTX is effective and safe for MG [1]. We have the following comments and concerns.
PMID:32749769 | DOI:10.1111/ene.14461
Source: https://pubmed.ncbi.nlm.nih.gov/3274976 ... 2&v=2.11.4